MedTrace Logo

Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy

NCT03657849 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-03-21

Study results available
· View outcomes & findings →

Summary

This study compares the yield of 19-gauge needles vs 21-gauge needles during EBUS TBNA procedures.

Conditions

  • Enlarged Lymph Nodes (Excluding Infective)

Interventions

DEVICE

EBUS TBNA

All patients undergo EBUS TBNA with two needle sizes

Sponsors & Collaborators

  • HealthPartners Institute

    lead OTHER

Principal Investigators

  • Firas S Elmufdi, MBBS · Regions Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-18
Primary Completion
2019-01-25
Completion
2019-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03657849 on ClinicalTrials.gov